BIT 0.00% 3.2¢ biotron limited

Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in...

  1. 229 Posts.
    lightbulb Created with Sketch. 355
    Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers

    https://www.researchsquare.com/article/rs-77124/v1

    The envelope (E) protein of SARS-CoV-2 assembles into a cation-selective channel that mediates virus budding, release, and host inflammation response. E blockage reduces virus pathogenicity while E deletion attenuates the virus.

    These results indicate that SARS-CoV-2 E forms a structurally robust but bipartite channel whose N- and C-terminal halves can interact with drugs, ions and other viral and host proteins semi-independently. This structure establishes the atomic basis for designing E inhibitors as antiviral drugs against SARS-CoV-2.

    https://www.researchsquare.com/article/rs-77124/v1.pdf

    The PDF link above goes into great detail about examination of the E Protein and how to approach accessing the E Protein for an effective result with Covid 19 - If you haven't already spoken to these researches Michelle Miller - you really should!
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $17.40K 542.8K

Buyers (Bids)

No. Vol. Price($)
1 17000 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 120000 2
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.